| Symbol | MGRX |
|---|---|
| Name | MANGOCEUTICALS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Misc Health and Biotechnology Services |
| Address | Texas, 75248, United States |
| Telephone | (833) 626-4679 |
| Fax | — |
| — | |
| Website | https://www.mangoceuticals.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001938046 |
| Description | Mangoceuticals, Inc. focuses on develops, markets, and sells various mens wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc. Additional info from NASDAQ: |
New Form 10-K - MANGOCEUTICALS, INC. <b>Filed:</b> 2026-04-01 <b>AccNo:</b> 0001493152-26-014478 <b>Size:</b> 16 MB
Read moreMangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
Read moreMangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
Read more(10% Negative) Mangoceuticals Inc (MGRX) Announces Delay in pioneer Trials for Tamil Nadu Due to Geopolitical Situation, Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment
Read moreMangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
Read moreMangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
Read more